 | • レポートコード：MRC2102QY15452 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の腫瘍壊死因子受容体スーパーファミリーメンバー4市場について種類別（ATOR-1015、ENUM-004、GBR-8383、GSK-3174998、その他）、用途別（卵、免疫、皮膚科、胃腸、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・腫瘍壊死因子受容体スーパーファミリーメンバー4市場の概要 ・世界の主要地域別腫瘍壊死因子受容体スーパーファミリーメンバー4市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の腫瘍壊死因子受容体スーパーファミリーメンバー4市場規模2015-2026：種類別（ATOR-1015、ENUM-004、GBR-8383、GSK-3174998、その他） ・世界の腫瘍壊死因子受容体スーパーファミリーメンバー4市場規模2015-2026：用途別（卵、免疫、皮膚科、胃腸、その他） ・腫瘍壊死因子受容体スーパーファミリーメンバー4の米国市場規模2015-2020 ・腫瘍壊死因子受容体スーパーファミリーメンバー4のヨーロッパ市場規模2015-2020 ・腫瘍壊死因子受容体スーパーファミリーメンバー4の中国市場規模2015-2020 ・腫瘍壊死因子受容体スーパーファミリーメンバー4の日本市場規模2015-2020 ・腫瘍壊死因子受容体スーパーファミリーメンバー4の東南アジア市場規模2015-2020 ・腫瘍壊死因子受容体スーパーファミリーメンバー4のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・腫瘍壊死因子受容体スーパーファミリーメンバー4の製造コスト分析 ・販売チャネル、流通業者、顧客 ・腫瘍壊死因子受容体スーパーファミリーメンバー4の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market
The global Tumor Necrosis Factor Receptor Superfamily Member 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Tumor Necrosis Factor Receptor Superfamily Member 4 Scope and Market Size
The global Tumor Necrosis Factor Receptor Superfamily Member 4 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Necrosis Factor Receptor Superfamily Member 4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Tumor Necrosis Factor Receptor Superfamily Member 4 market is segmented into
ATOR-1015
ENUM-004
GBR-8383
GSK-3174998
Others
Segment by Application, the Tumor Necrosis Factor Receptor Superfamily Member 4 market is segmented into
Oocology
Immunology
Dermatology
Gastrointestinal
Others
The Tumor Necrosis Factor Receptor Superfamily Member 4 market is analysed and market size information is provided by regions (countries). Segment by Application, the Tumor Necrosis Factor Receptor Superfamily Member 4 market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tumor Necrosis Factor Receptor Superfamily Member 4 Market Share Analysis
Tumor Necrosis Factor Receptor Superfamily Member 4 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tumor Necrosis Factor Receptor Superfamily Member 4 business, the date to enter into the Tumor Necrosis Factor Receptor Superfamily Member 4 market, Tumor Necrosis Factor Receptor Superfamily Member 4 product introduction, recent developments, etc.
The major vendors covered:
Abeome Corp
Alligator Bioscience AB
Apogenix GmbH
BioInvent International AB
Bristol-Myers Squibb Company
Denceptor Therapeutics Ltd
Enumeral Biomedical Holdings Inc
GlaxoSmithKline Plc
Glenmark Pharmaceuticals Ltd
Incyte Corp
Kyowa Hakko Kirin Co Ltd
MedImmune LLC
Pfizer Inc
1 Tumor Necrosis Factor Receptor Superfamily Member 4 Market Overview
1.1 Tumor Necrosis Factor Receptor Superfamily Member 4 Product Scope
1.2 Tumor Necrosis Factor Receptor Superfamily Member 4 Segment by Type
1.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales by Type (2020-2026)
1.2.2 ATOR-1015
1.2.3 ENUM-004
1.2.4 GBR-8383
1.2.5 GSK-3174998
1.2.6 Others
1.3 Tumor Necrosis Factor Receptor Superfamily Member 4 Segment by Application
1.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Comparison by Application (2020-2026)
1.3.2 Oocology
1.3.3 Immunology
1.3.4 Dermatology
1.3.5 Gastrointestinal
1.3.6 Others
1.4 Tumor Necrosis Factor Receptor Superfamily Member 4 Market Estimates and Forecasts (2015-2026)
1.4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Growth Rate (2015-2026)
1.4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue and Growth Rate (2015-2026)
1.4.3 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Price Trends (2015-2026)
2 Tumor Necrosis Factor Receptor Superfamily Member 4 Estimate and Forecast by Region
2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Region (2015-2020)
2.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Market Share by Region (2015-2020)
2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Tumor Necrosis Factor Receptor Superfamily Member 4 Estimates and Projections (2015-2026)
2.4.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Estimates and Projections (2015-2026)
2.4.3 China Tumor Necrosis Factor Receptor Superfamily Member 4 Estimates and Projections (2015-2026)
2.4.4 Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Estimates and Projections (2015-2026)
2.4.6 India Tumor Necrosis Factor Receptor Superfamily Member 4 Estimates and Projections (2015-2026)
3 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Competition Landscape by Players
3.1 Global Top Tumor Necrosis Factor Receptor Superfamily Member 4 Players by Sales (2015-2020)
3.2 Global Top Tumor Necrosis Factor Receptor Superfamily Member 4 Players by Revenue (2015-2020)
3.3 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Necrosis Factor Receptor Superfamily Member 4 as of 2019)
3.4 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Average Price by Company (2015-2020)
3.5 Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 4 Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Tumor Necrosis Factor Receptor Superfamily Member 4 Players (Opinion Leaders)
4 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market Size by Type
4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Historic Market Review by Type (2015-2020)
4.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type (2015-2020)
4.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Market Share by Type (2015-2020)
4.1.3 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Price by Type (2015-2020)
4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Forecast by Type (2021-2026)
4.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Forecast by Type (2021-2026)
4.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Price Forecast by Type (2021-2026)
5 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market Size by Application
5.1 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Historic Market Review by Application (2015-2020)
5.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application (2015-2020)
5.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Market Share by Application (2015-2020)
5.1.3 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Price by Application (2015-2020)
5.2 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Forecast by Application (2021-2026)
5.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Forecast by Application (2021-2026)
5.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 4 Price Forecast by Application (2021-2026)
6 United States Tumor Necrosis Factor Receptor Superfamily Member 4 Market Facts & Figures
6.1 United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company (2015-2020)
6.2 United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type (2015-2020)
6.3 United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application (2015-2020)
7 Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Market Facts & Figures
7.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company (2015-2020)
7.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type (2015-2020)
7.3 Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application (2015-2020)
8 China Tumor Necrosis Factor Receptor Superfamily Member 4 Market Facts & Figures
8.1 China Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company (2015-2020)
8.2 China Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type (2015-2020)
8.3 China Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application (2015-2020)
9 Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Market Facts & Figures
9.1 Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company (3015-3030)
9.2 Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type (2015-2020)
9.3 Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application (2015-2020)
10 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Market Facts & Figures
10.1 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application (2015-2020)
11 India Tumor Necrosis Factor Receptor Superfamily Member 4 Market Facts & Figures
11.1 India Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company (2015-2020)
11.2 India Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type (2015-2020)
11.3 India Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Tumor Necrosis Factor Receptor Superfamily Member 4 Business
12.1 Abeome Corp
12.1.1 Abeome Corp Corporation Information
12.1.2 Abeome Corp Business Overview
12.1.3 Abeome Corp Tumor Necrosis Factor Receptor Superfamily Member 4 Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Abeome Corp Tumor Necrosis Factor Receptor Superfamily Member 4 Products Offered
12.1.5 Abeome Corp Recent Development
12.2 Alligator Bioscience AB
12.2.1 Alligator Bioscience AB Corporation Information
12.2.2 Alligator Bioscience AB Business Overview
12.2.3 Alligator Bioscience AB Tumor Necrosis Factor Receptor Superfamily Member 4 Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Alligator Bioscience AB Tumor Necrosis Factor Receptor Superfamily Member 4 Products Offered
12.2.5 Alligator Bioscience AB Recent Development
12.3 Apogenix GmbH
12.3.1 Apogenix GmbH Corporation Information
12.3.2 Apogenix GmbH Business Overview
12.3.3 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 4 Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 4 Products Offered
12.3.5 Apogenix GmbH Recent Development
12.4 BioInvent International AB
12.4.1 BioInvent International AB Corporation Information
12.4.2 BioInvent International AB Business Overview
12.4.3 BioInvent International AB Tumor Necrosis Factor Receptor Superfamily Member 4 Sales, Revenue and Gross Margin (2015-2020)
12.4.4 BioInvent International AB Tumor Necrosis Factor Receptor Superfamily Member 4 Products Offered
12.4.5 BioInvent International AB Recent Development
12.5 Bristol-Myers Squibb Company
12.5.1 Bristol-Myers Squibb Company Corporation Information
12.5.2 Bristol-Myers Squibb Company Business Overview
12.5.3 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 4 Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 4 Products Offered
12.5.5 Bristol-Myers Squibb Company Recent Development
12.6 Denceptor Therapeutics Ltd
12.6.1 Denceptor Therapeutics Ltd Corporation Information
12.6.2 Denceptor Therapeutics Ltd Business Overview
12.6.3 Denceptor Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 4 Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Denceptor Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 4 Products Offered
12.6.5 Denceptor Therapeutics Ltd Recent Development
12.7 Enumeral Biomedical Holdings Inc
12.7.1 Enumeral Biomedical Holdings Inc Corporation Information
12.7.2 Enumeral Biomedical Holdings Inc Business Overview
12.7.3 Enumeral Biomedical Holdings Inc Tumor Necrosis Factor Receptor Superfamily Member 4 Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Enumeral Biomedical Holdings Inc Tumor Necrosis Factor Receptor Superfamily Member 4 Products Offered
12.7.5 Enumeral Biomedical Holdings Inc Recent Development
12.8 GlaxoSmithKline Plc
12.8.1 GlaxoSmithKline Plc Corporation Information
12.8.2 GlaxoSmithKline Plc Business Overview
12.8.3 GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 4 Sales, Revenue and Gross Margin (2015-2020)
12.8.4 GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 4 Products Offered
12.8.5 GlaxoSmithKline Plc Recent Development
12.9 Glenmark Pharmaceuticals Ltd
12.9.1 Glenmark Pharmaceuticals Ltd Corporation Information
12.9.2 Glenmark Pharmaceuticals Ltd Business Overview
12.9.3 Glenmark Pharmaceuticals Ltd Tumor Necrosis Factor Receptor Superfamily Member 4 Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Glenmark Pharmaceuticals Ltd Tumor Necrosis Factor Receptor Superfamily Member 4 Products Offered
12.9.5 Glenmark Pharmaceuticals Ltd Recent Development
12.10 Incyte Corp
12.10.1 Incyte Corp Corporation Information
12.10.2 Incyte Corp Business Overview
12.10.3 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 4 Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 4 Products Offered
12.10.5 Incyte Corp Recent Development
12.11 Kyowa Hakko Kirin Co Ltd
12.11.1 Kyowa Hakko Kirin Co Ltd Corporation Information
12.11.2 Kyowa Hakko Kirin Co Ltd Business Overview
12.11.3 Kyowa Hakko Kirin Co Ltd Tumor Necrosis Factor Receptor Superfamily Member 4 Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Kyowa Hakko Kirin Co Ltd Tumor Necrosis Factor Receptor Superfamily Member 4 Products Offered
12.11.5 Kyowa Hakko Kirin Co Ltd Recent Development
12.12 MedImmune LLC
12.12.1 MedImmune LLC Corporation Information
12.12.2 MedImmune LLC Business Overview
12.12.3 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 4 Sales, Revenue and Gross Margin (2015-2020)
12.12.4 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 4 Products Offered
12.12.5 MedImmune LLC Recent Development
12.13 Pfizer Inc
12.13.1 Pfizer Inc Corporation Information
12.13.2 Pfizer Inc Business Overview
12.13.3 Pfizer Inc Tumor Necrosis Factor Receptor Superfamily Member 4 Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Pfizer Inc Tumor Necrosis Factor Receptor Superfamily Member 4 Products Offered
12.13.5 Pfizer Inc Recent Development
13 Tumor Necrosis Factor Receptor Superfamily Member 4 Manufacturing Cost Analysis
13.1 Tumor Necrosis Factor Receptor Superfamily Member 4 Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Tumor Necrosis Factor Receptor Superfamily Member 4
13.4 Tumor Necrosis Factor Receptor Superfamily Member 4 Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Tumor Necrosis Factor Receptor Superfamily Member 4 Distributors List
14.3 Tumor Necrosis Factor Receptor Superfamily Member 4 Customers
15 Market Dynamics
15.1 Tumor Necrosis Factor Receptor Superfamily Member 4 Market Trends
15.2 Tumor Necrosis Factor Receptor Superfamily Member 4 Opportunities and Drivers
15.3 Tumor Necrosis Factor Receptor Superfamily Member 4 Market Challenges
15.4 Tumor Necrosis Factor Receptor Superfamily Member 4 Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Tumor Necrosis Factor Receptor Superfamily Member 4 Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Region (2015-2020)
Table 5. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Region (2015-2020)
Table 6. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Share by Region (2015-2020)
Table 8. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Share Forecast by Region (2021-2026)
Table 12. Global Tumor Necrosis Factor Receptor Superfamily Member 4 (K Units) of Key Companies (2015-2020)
Table 13. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Share by Company (2015-2020)
Table 14. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Share by Company (2015-2020)
Table 16. Global Tumor Necrosis Factor Receptor Superfamily Member 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Necrosis Factor Receptor Superfamily Member 4 as of 2019)
Table 17. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 4 Manufacturing Sites and Area Served
Table 19. Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 4 Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Tumor Necrosis Factor Receptor Superfamily Member 4 Players
Table 22. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Type (2015-2020)
Table 23. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Share by Type (2015-2020)
Table 24. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Price (K Units) by Type (2015-2020)
Table 26. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Share by Type (2021-2026)
Table 27. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Share by Type (2021-2026)
Table 29. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Price (K Units) by Type (2021-2026)
Table 30. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Application (2015-2020)
Table 31. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Share by Application (2015-2020)
Table 32. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Price (K Units) by Application (2015-2020)
Table 34. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Application (2021-2026)
Table 35. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Share by Application (2021-2026)
Table 36. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Share by Application (2021-2026)
Table 38. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Price (K Units) by Application (2021-2026)
Table 39. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Company (2015-2020)
Table 40. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company (2015-2020)
Table 41. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Type (2015-2020)
Table 42. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type (2015-2020)
Table 43. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Application (2015-2020)
Table 44. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application (2015-2020)
Table 45. Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Company (2015-2020)
Table 46. Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company (2015-2020)
Table 47. Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Type (2015-2020)
Table 48. Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type (2015-2020)
Table 49. Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Application (2015-2020)
Table 50. Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type (2015-2020)
Table 51. China Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Company (2015-2020)
Table 52. China Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company (2015-2020)
Table 53. China Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Type (2015-2020)
Table 54. China Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type (2015-2020)
Table 55. China Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Application (2015-2020)
Table 56. China Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application (2015-2020)
Table 57. Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Company (2015-2020)
Table 58. Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company (2015-2020)
Table 59. Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Type (2015-2020)
Table 60. Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type (2015-2020)
Table 61. Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Application (2015-2020)
Table 62. Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application (2015-2020)
Table 69. India Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Company (2015-2020)
Table 70. India Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company (2015-2020)
Table 71. India Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Type (2015-2020)
Table 72. India Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type (2015-2020)
Table 73. India Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) by Application (2015-2020)
Table 74. India Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application (2015-2020)
Table 75. Abeome Corp Corporation Information
Table 76. Abeome Corp Description and Business Overview
Table 77. Abeome Corp Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Abeome Corp Tumor Necrosis Factor Receptor Superfamily Member 4 Product
Table 79. Abeome Corp Recent Development
Table 80. Alligator Bioscience AB Corporation Information
Table 81. Alligator Bioscience AB Description and Business Overview
Table 82. Alligator Bioscience AB Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Alligator Bioscience AB Tumor Necrosis Factor Receptor Superfamily Member 4 Product
Table 84. Alligator Bioscience AB Recent Development
Table 85. Apogenix GmbH Corporation Information
Table 86. Apogenix GmbH Description and Business Overview
Table 87. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 4 Product
Table 89. Apogenix GmbH Recent Development
Table 90. BioInvent International AB Corporation Information
Table 91. BioInvent International AB Description and Business Overview
Table 92. BioInvent International AB Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. BioInvent International AB Tumor Necrosis Factor Receptor Superfamily Member 4 Product
Table 94. BioInvent International AB Recent Development
Table 95. Bristol-Myers Squibb Company Corporation Information
Table 96. Bristol-Myers Squibb Company Description and Business Overview
Table 97. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 4 Product
Table 99. Bristol-Myers Squibb Company Recent Development
Table 100. Denceptor Therapeutics Ltd Corporation Information
Table 101. Denceptor Therapeutics Ltd Description and Business Overview
Table 102. Denceptor Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Denceptor Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 4 Product
Table 104. Denceptor Therapeutics Ltd Recent Development
Table 105. Enumeral Biomedical Holdings Inc Corporation Information
Table 106. Enumeral Biomedical Holdings Inc Description and Business Overview
Table 107. Enumeral Biomedical Holdings Inc Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Enumeral Biomedical Holdings Inc Tumor Necrosis Factor Receptor Superfamily Member 4 Product
Table 109. Enumeral Biomedical Holdings Inc Recent Development
Table 110. GlaxoSmithKline Plc Corporation Information
Table 111. GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. GlaxoSmithKline Plc Description and Business Overview
Table 113. GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 4 Product
Table 114. GlaxoSmithKline Plc Recent Development
Table 115. Glenmark Pharmaceuticals Ltd Corporation Information
Table 116. Glenmark Pharmaceuticals Ltd Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Glenmark Pharmaceuticals Ltd Description and Business Overview
Table 118. Glenmark Pharmaceuticals Ltd Tumor Necrosis Factor Receptor Superfamily Member 4 Product
Table 119. Glenmark Pharmaceuticals Ltd Recent Development
Table 120. Incyte Corp Corporation Information
Table 121. Incyte Corp Description and Business Overview
Table 122. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 4 Product
Table 124. Incyte Corp Recent Development
Table 125. Kyowa Hakko Kirin Co Ltd Corporation Information
Table 126. Kyowa Hakko Kirin Co Ltd Description and Business Overview
Table 127. Kyowa Hakko Kirin Co Ltd Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Kyowa Hakko Kirin Co Ltd Tumor Necrosis Factor Receptor Superfamily Member 4 Product
Table 129. Kyowa Hakko Kirin Co Ltd Recent Development
Table 130. MedImmune LLC Corporation Information
Table 131. MedImmune LLC Description and Business Overview
Table 132. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 4 Product
Table 134. MedImmune LLC Recent Development
Table 135. Pfizer Inc Corporation Information
Table 136. Pfizer Inc Description and Business Overview
Table 137. Pfizer Inc Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Pfizer Inc Tumor Necrosis Factor Receptor Superfamily Member 4 Product
Table 139. Pfizer Inc Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Tumor Necrosis Factor Receptor Superfamily Member 4 Distributors List
Table 143. Tumor Necrosis Factor Receptor Superfamily Member 4 Customers List
Table 144. Tumor Necrosis Factor Receptor Superfamily Member 4 Market Key Trends
Table 145. Tumor Necrosis Factor Receptor Superfamily Member 4 Key Opportunities and Drivers
Table 146. Tumor Necrosis Factor Receptor Superfamily Member 4 Market Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Tumor Necrosis Factor Receptor Superfamily Member 4 Product Picture
Figure 2. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market Share by Application in 2020 & 2026
Figure 6. Oocology Examples
Figure 7. Immunology Examples
Figure 8. Dermatology Examples
Figure 9. Gastrointestinal Examples
Figure 10. Others Examples
Figure 11. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) Growth Rate (2015-2026)
Figure 12. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 14. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units) Growth Rate (2015-2026)
Figure 18. Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Tumor Necrosis Factor Receptor Superfamily Member 4 Players Market Share by Revenue in Tumor Necrosis Factor Receptor Superfamily Member 4 2015 & 2019
Figure 29. Tumor Necrosis Factor Receptor Superfamily Member 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Share by Type (2015-2020)
Figure 31. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Share by Application (2015-2020)
Figure 33. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type in 2019
Figure 35. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type in 2019
Figure 36. Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company in 2019
Figure 37. Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type in 2019
Figure 38. Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application in 2019
Figure 39. China Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company in 2019
Figure 40. China Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type in 2019
Figure 41. China Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application in 2019
Figure 42. Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company in 2019
Figure 43. Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type in 2019
Figure 44. Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application in 2019
Figure 45. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company in 2019
Figure 46. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type in 2019
Figure 47. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application in 2019
Figure 48. India Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Company in 2019
Figure 49. India Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Type in 2019
Figure 50. India Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share by Application in 2019
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Tumor Necrosis Factor Receptor Superfamily Member 4
Figure 53. Manufacturing Process Analysis of Tumor Necrosis Factor Receptor Superfamily Member 4
Figure 54. Tumor Necrosis Factor Receptor Superfamily Member 4 Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
腫瘍壊死因子受容体スーパーファミリーメンバー1Aの世界市場レポート2020 Market Analysis and Insights: Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market The global Tumor Necrosis Factor Receptor Superfamily Member 1A market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Tumor Necr…- 腫瘍壊死因子受容体スーパーファミリーメンバー18の世界市場レポート2020 Market Analysis and Insights: Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market The global Tumor Necrosis Factor Receptor Superfamily Member 18 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Tumor Necr…
- ヒト凝固因子VIIの世界市場レポート2020 Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activa…
- 凝固因子濃縮物の世界市場レポート2020 Market Analysis and Insights: Global Coagulation Factor Concentrate Market The global Coagulation Factor Concentrate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Coagulation Factor Concentrate Scope and Market Size T…
- インシュリン様成長因子IIの世界市場レポート2020 Market Analysis and Insights: Global Insulin Like Growth Factor II Market The global Insulin Like Growth Factor II market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Insulin Like Growth Factor II Scope and Market Size The …